GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Net Margin %

Oxford BioDynamics (LSE:OBD) Net Margin % : -2,201.03% (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Oxford BioDynamics's Net Income for the six months ended in Sep. 2023 was £-6.38 Mil. Oxford BioDynamics's Revenue for the six months ended in Sep. 2023 was £0.29 Mil. Therefore, Oxford BioDynamics's net margin for the quarter that ended in Sep. 2023 was -2,201.03%.

The historical rank and industry rank for Oxford BioDynamics's Net Margin % or its related term are showing as below:

LSE:OBD' s Net Margin % Range Over the Past 10 Years
Min: -4357.14   Med: -315.14   Max: -111.68
Current: -2122.75


LSE:OBD's Net Margin % is ranked worse than
81.11% of 1027 companies
in the Biotechnology industry
Industry Median: -162.58 vs LSE:OBD: -2122.75

Oxford BioDynamics Net Margin % Historical Data

The historical data trend for Oxford BioDynamics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Net Margin % Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -308.71 -953.73 -1,959.53 -4,357.14 -2,122.75

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,959.34 -3,397.65 -5,539.13 -2,019.55 -2,201.03

Competitive Comparison of Oxford BioDynamics's Net Margin %

For the Biotechnology subindustry, Oxford BioDynamics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Net Margin % falls into.



Oxford BioDynamics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Oxford BioDynamics's Net Margin for the fiscal year that ended in Sep. 2023 is calculated as

Net Margin=Net Income (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-10.826/0.51
=-2,122.75 %

Oxford BioDynamics's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-6.383/0.29
=-2,201.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics  (LSE:OBD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Oxford BioDynamics Net Margin % Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics (LSE:OBD) Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (LSE:OBD) Headlines

No Headlines